XML 47 R34.htm IDEA: XBRL DOCUMENT v3.25.1
Revenues (Tables)
 3 Months Ended
Mar. 31, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of Product Revenue The table below presents the Company’s gross and net product revenue ($ in thousands):
Three Months Ended March 31,
20252024
Product revenue - gross112,333 93,112 
Less: Rebates and sales returns(6,683)(5,963)
Product revenue - net105,650 87,149 
Schedule of Disaggregation of Net Revenue
The following table presents the Company’s net revenue by commercial program ($ in thousands):
Three Months Ended March 31,
20252024
ZEJULA49,529 45,501 
VYVGART / VYVGART Hytrulo18,105 13,162 
NUZYRA15,118 9,913 
OPTUNE11,363 12,480 
QINLOCK8,509 6,093 
XACDURO1,117 — 
AUGTYRO1,626 — 
Other (i)283 — 
Product revenue - net105,650 87,149 
(i)Other includes product candidates sold in patient programs prior to commercialization.